Trial Profile
Pharmacokinetics/pharmacodynamics of Levornidazole in patients with intra- abdominal anaerobic infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2018
Price :
$35
*
At a glance
- Drugs Levornidazole (Primary)
- Indications Anaerobic infections
- Focus Pharmacokinetics
- Sponsors Nanjing Sanhome Pharmaceutical
- 23 Aug 2018 Results published in the Clinical Therapeutics
- 03 Apr 2018 New trial record